Published in J Am Coll Cardiol on July 24, 2006
Cardiac stimulation with high voltage discharge from stun guns. CMAJ (2008) 1.17
Electronic control devices and the clinical milieu. J Am Coll Cardiol (2007) 1.08
The physiologic effects of multiple simultaneous electronic control device discharges. West J Emerg Med (2010) 0.81
Electromuscular incapacitating devices discharge and risk of severe bradycardia. Am J Forensic Med Pathol (2015) 0.75
Taser research in pigs not helpful. J Am Coll Cardiol (2007) 0.75
[Medical aspects of common non-lethal weapons]. Wien Med Wochenschr (2013) 0.75
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol (2012) 2.96
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol (2012) 2.77
Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation (2004) 2.74
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm (2012) 2.65
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J (2005) 2.39
Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail (2012) 2.13
Body surface projection of action potential duration alternans: a combined clinical-modeling study with implications for improving T-wave alternans detection. Heart Rhythm (2009) 2.11
Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J (2002) 2.09
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol (2006) 2.06
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans. J Am Coll Cardiol (2007) 1.96
Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. Resuscitation (2010) 1.93
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol (2011) 1.91
A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med (2013) 1.91
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation (2006) 1.86
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J (2012) 1.82
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol (2005) 1.78
Ventricular fibrillation in myopathic human hearts: mechanistic insights from in vivo global endocardial and epicardial mapping. Am J Physiol Heart Circ Physiol (2007) 1.75
The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J (2004) 1.74
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J (2006) 1.73
The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol (2004) 1.72
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol (2006) 1.70
Does this patient with palpitations have a cardiac arrhythmia? JAMA (2009) 1.63
Cardiac arrest survival did not increase in the Resuscitation Outcomes Consortium after implementation of the 2005 AHA CPR and ECC guidelines. Resuscitation (2011) 1.62
Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng (2009) 1.61
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol (2004) 1.58
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol (2011) 1.58
Management of cardiac arrest in pregnancy: a systematic review. Resuscitation (2011) 1.56
Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry. Circ Arrhythm Electrophysiol (2012) 1.56
Atrial dyssynchrony syndrome: an overlooked phenomenon and a potential cause of 'diastolic' heart failure. Eur J Heart Fail (2012) 1.55
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol (2010) 1.55
n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm (2009) 1.54
Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol (2009) 1.53
Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation (2009) 1.52
Improving use of targeted temperature management after out-of-hospital cardiac arrest: a stepped wedge cluster randomized controlled trial. Crit Care Med (2015) 1.52
The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. J Am Coll Cardiol (2011) 1.49
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial. Circ Heart Fail (2012) 1.47
The benefits of a simplified method for CPR training of medical professionals: a randomized controlled study. Resuscitation (2013) 1.46
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
Targeted temperature management processes and outcomes after out-of-hospital cardiac arrest: an observational cohort study*. Crit Care Med (2014) 1.43
Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 1: rationale and methodology for the impedance threshold device (ITD) protocol. Resuscitation (2008) 1.43
Real-time electrogram analysis for monitoring coronary blood flow during human ventricular fibrillation: implications for CPR. Heart Rhythm (2010) 1.42
Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol (2010) 1.41
Systematic evaluation of the determinants of defibrillation efficacy. Heart Rhythm (2005) 1.40
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.40
Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used. J Cardiovasc Pharmacol Ther (2003) 1.39
Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). J Thorac Cardiovasc Surg (2003) 1.39
Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm (2007) 1.33
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol (2005) 1.25
Evaluation and care of a patient with new-onset atrial fibrillation. CMAJ (2013) 1.23
Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol (2007) 1.21
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol (2009) 1.21
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol (2003) 1.18
Cardiac stimulation with high voltage discharge from stun guns. CMAJ (2008) 1.17
Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction. CMAJ (2004) 1.17
Paradoxical extranodal response during para-Hisian pacing: what is the mechanism? Pacing Clin Electrophysiol (2009) 1.16
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol (2011) 1.16
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol (2009) 1.10
A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ (2003) 1.10
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ (2008) 1.08
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm (2014) 1.08
Factors associated with 90-day death after emergency department discharge for atrial fibrillation. Ann Emerg Med (2013) 1.08
Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery. J Am Coll Cardiol (2010) 1.07
Intramural activation during early human ventricular fibrillation. Circ Arrhythm Electrophysiol (2011) 1.06
Phase mapping of cardiac fibrillation. Circ Arrhythm Electrophysiol (2010) 1.05
Out-of-hospital cardiac arrest frequency and survival: evidence for temporal variability. Resuscitation (2009) 1.05
A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation. Am Heart J (2004) 1.05
Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts. Circ Res (2011) 1.05
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. Can J Cardiol (2011) 1.03
Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol (2003) 1.02
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada. Can J Cardiol (2006) 1.02
Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg (2006) 1.01
Lithium-induced sinus node disease at therapeutic concentrations: linking lithium-induced blockade of sodium channels to impaired pacemaker activity. Can J Cardiol (2007) 1.01